SC 13G Filing

Company

RELMADA THERAPEUTICS, INC.

Filed

July 1, 2014

Accession Number

0001415889-14-002022

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →